IGI, Inc., a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, ...

Drill hole 30-1061, located near the western limit of the 2024 MRE model, intersected 172.5 metres averaging 0.18% Cu and ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

Research and development expenses for the first quarter of 2025 were $42.9 million versus $20.7 million for the comparable ...

The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

"We built an innovative offering that supports GXO's rapid growth and differentiation in a highly competitive market,” said ...

RESEARCH TRIANGLE PARK, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today reported ...

Mr. McElroy joins Apollo following the successful acquisition of Fission Uranium, a company he co-founded and eventually led ...

ONE week before Filipinos cast their votes on May 12, candidates from the administration-backed Alyansa Para sa Bagong ...

Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (" Hyperscale Data ” or the " Company ”), today ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ:FTAI) (the "Company”) today announced that Joe Adams, ...